Long intergenic non-protein coding RNA 2889 (LINC02889)

Long intergenic non-protein coding RNA 2889 (LINC02889) is a long intergenic non-coding RNA (lincRNA) gene. LINC02889 does not encode a protein but instead functions at the RNA level, likely involved in regulatory networks that modulate gene expression and contribute to cellular functions such as epigenetic regulation, circadian rhythm, and aspects of tumor biology[1][2][3]. LINC02889 has been identified as differentially expressed in malignant glioma and incorporated into prognostic models for this disease, suggesting its role as a potential biomarker[2]. Like other lincRNAs, LINC02889 is thought to regulate chromatin structure, modulate transcription, and participate in competing endogenous RNA (ceRNA) networks, but its precise mechanisms and interacting partners in most biological contexts are uncharacterized[3]. LINC02889 is not currently recognized as a therapeutic target (e.g., receptor, enzyme, transporter) and there are no drugs directly targeting it.

Other names

LINC02889Long intergenic non-protein coding RNA 2889